where does mochi get their semaglutide GL-P1 on a Budget with Health! FAQ | Mochi Health

Long-term safety data remains limited compared to semaglutide

In the very early stages of blood sugar correction, the body may shed some initial water weight that was previously held to dilute high systemic glucose levels, simulating a transient state of increased fluid turnover

Companies are racing to develop alternatives to injectable diabetes and weight loss drugs Injectable peptide drugs targeting the glucagon-like peptide 1 (GLP-1) receptor have had massive impact on approaches to treating diabetes and obesity, bringing huge revenue boosts to makers Novo Nordisk and Eli Lilly

It is a metabolic strategy with measurable outcomes

Both trials support the cardiovascular benefits of GLP-1 medications, though a direct comparison is difficult due to different trial designs and populations